XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION AND EQUITY (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Stock-based Compensation Expense The following table details total stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022, included in the condensed consolidated statements of income:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2023202220232022
Costs of revenue (exclusive of amortization and depreciation)$237 $274 $558 $851 
Other expenses801 1,590 1,604 4,433 
Pre-tax stock-based compensation expense1,038 1,864 2,162 5,284 
Less: income tax effect(228)(410)(476)(1,162)
Net stock-based compensation expense$810 $1,454 $1,686 $4,122 
Schedule of Restricted Stock Activity
A summary of restricted stock activity under the Plan during the nine months ended September 30, 2023 and 2022 is as follows:
Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
SharesWeighted-Average
Grant Date
Fair Value Per Share
SharesWeighted-Average
Grant Date
Fair Value Per Share
Unvested restricted stock outstanding at beginning of period281,161 $32.24 314,883 $29.79 
Granted210,351 26.44 161,375 34.22 
Vested(145,529)31.35 (181,405)29.79 
Forfeited(2,668)29.23 (8,936)31.60 
Unvested restricted stock outstanding at end of period343,315 $29.08 285,917 $32.23 
Schedule of Performance Share Award Activity
A summary of performance share award activity under the Plan during the nine months ended September 30, 2023 and 2022 is as follows, based on the target award amounts set forth in the performance share award agreements:
Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
SharesWeighted-Average
Grant Date
Fair Value Per Share
SharesWeighted-Average
Grant Date
Fair Value Per Share
Performance share awards outstanding at beginning of period252,375 $31.84 249,952 $29.59 
Granted122,071 31.21 101,799 37.98 
Forfeited or unearned(100,655)27.46 (45,060)31.70 
Earned and issued— — (27,317)31.75 
Performance share awards outstanding at end of period273,791 $33.17 279,374 $32.09